Company Filing History:
Years Active: 2001
Title: Roderick N Hobbs: Innovator in Synthetic Particles for Analyte Detection
Introduction
Roderick N Hobbs is a notable inventor based in Chester, GB. He has made significant contributions to the field of diagnostics through his innovative work on synthetic particles used as agglutination reagents. His research focuses on improving methods for detecting analytes in liquid samples, which has important implications for various scientific and medical applications.
Latest Patents
Hobbs holds a patent for a method and reagent kit titled "Synthetic particles as agglutination reagents." This patent describes a technique for detecting an analyte in a sample liquid by agglutination. The process involves contacting the sample liquid with an agglutination reagent in a reaction vessel containing an inert matrix. The resulting reaction mixture is subjected to centrifugation, allowing for the determination of the interaction between the analyte and the agglutination reagent based on the reagent's penetration into the inert matrix. The synthetic particles used in this method are designed to mimic the sedimentation behavior of erythrocytes, enhancing the accuracy of the detection process.
Career Highlights
Hobbs is associated with Stiftung für Diagnostische Forschung, where he continues to advance his research in diagnostic technologies. His work has led to the development of innovative solutions that improve the efficiency and reliability of analyte detection.
Collaborations
Throughout his career, Hobbs has collaborated with esteemed colleagues such as Peter Schwind and David Bashforth. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of diagnostics.
Conclusion
Roderick N Hobbs is a pioneering inventor whose work on synthetic particles for agglutination reagents has the potential to transform diagnostic practices. His contributions to the field highlight the importance of innovation in improving healthcare solutions.